Mackay Shields LLC Editas Medicine, Inc. Transaction History

Mackay Shields LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $969,739 - $1.76 Million	-30,992 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$39.71 - $90.58 $1.46 Million - $3.33 Million	-36,734 Reduced 54.24%	30,992 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $162,420 - $506,099	6,000 Added 9.72%	67,726 $4.75 Million
Q3 2020 Nov 04, 2020	SELL	$28.06 - $37.16 $336,720 - $445,919	-12,000 Reduced 16.28%	61,726 $1.73 Million
Q2 2020 Jul 31, 2020	BUY	$18.5 - $34.34 $160,950 - $298,758	8,700 Added 13.38%	73,726 $2.18 Million
Q1 2020 May 08, 2020	BUY	$14.88 - $32.78 $11,904 - $26,224	800 Added 1.25%	65,026 $1.29 Million
Q4 2019 Feb 11, 2020	BUY	$19.49 - $32.63 $64,316 - $107,679	3,300 Added 5.42%	64,226 $1.9 Million
Q3 2019 Nov 01, 2019	BUY	$22.49 - $26.81 $13,493 - $16,086	600 Added 0.99%	60,926 $1.39 Million
Q2 2019 Aug 13, 2019	BUY	$20.48 - $27.76 $791,224 - $1.07 Million	38,634 Added 178.1%	60,326 $1.49 Million
Q1 2019 May 13, 2019	BUY	$19.43 - $26.41 $21,373 - $29,051	1,100 Added 5.34%	21,692 $531,000
Q4 2018 Feb 14, 2019	SELL	$18.19 - $31.79 $32,887 - $57,476	-1,808 Reduced 8.07%	20,592 $469,000
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $160,370 - $222,662	5,800 Added 34.94%	22,400 $713,000
Q2 2018 Aug 06, 2018	BUY	$31.4 - $41.01 $521,240 - $680,766	16,600 New	16,600 $595,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $104M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.